January 2025 Br J Cardiol 2025;32(1) doi:10.5837/bjc.2025.004 Online First
Hibba Kurdi, Henry Procter, Matthew Aldred, Katie Linden, Angela Langton, Akriti Naraen, Kathryn Abernethy, Sabrina Nordin, Ashwin Roy, Ben Leach, James Moon, Derralynn Hughes
Introduction Fabry disease is a rare X-chromosome-linked disorder that results from alpha-galactosidase A enzyme deficiency. It is broadly divided into classical (earlier onset, low enzyme activity) and non-classical (milder, later-onset and some residual activity). It is underdiagnosed despite the availability of diagnostic tests, such as blood (plasma or leucocyte alpha-galactosidase A enzyme) and genetic testing. Due to its heterogeneous nature as a multi-system disorder, Fabry disease (FD) is rarely considered. Patients often present with non-specific symptoms, such as fatigue and gastrointestinal symptoms akin to irritable bowel, taking
April 2021 doi:10.5837/bjc.2021.015
Joseph M Krepp, Richard Katz, Rachel Volke, Angela Ryan, Gurusher Panjrath
Case presentation An 83-year-old man presented with progressive shortness of breath and moderate lower extremity oedema over a period of several months. His past medical history is notable for hypertension, non-insulin dependent diabetes, bilateral carpal tunnel syndrome and aortic stenosis. At the time of presentation he was found to have new-onset atrial flutter with rapid ventricular response. An echocardiogram demonstrated moderate concentric left ventricular hypertrophy and moderate aortic stenosis with an ejection fraction of 55% and mildly reduced right ventricular function. A left heart catheterisation confirmed the presence of modera
March 2014 Br J Cardiol 2014;21:17–9
Heather Wetherell
(more…)
July 2004 Br J Cardiol 2004;11:315-20
Michael Kirby, Rubin Minhas
No content available
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits